Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SPR | P35270 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 5/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19243956 | 0.95 | MEN1 (0.41) | TSHRMEN1KMT2ASPRHPGD | |
| SCHEMBL13226788 | 0.93 | MEN1 (0.42) | TSHRMEN1KMT2ASPRHPGD | |
| SCHEMBL23173479 | 0.93 | MEN1 (0.42) | TSHRMEN1KMT2ASPRHPGD | |
| SCHEMBL13531884 | 0.89 | HPGD (0.45) | TSHRHPGDCYP1A2CYP2C19CYP2C9 | |
| SCHEMBL8536337 | 0.89 | TSHR (0.45) | TSHRMEN1KMT2ASPRHPGD | |
| SCHEMBL12734797 | 0.88 | TSHR (0.41) | TSHRMEN1KMT2AHPGDCYP1A2 | |
| SCHEMBL29330747 | 0.88 | TSHR (0.41) | TSHRMEN1KMT2AHPGDCYP1A2 | |
| SCHEMBL8537552 | 0.87 | MEN1 (0.48) | TSHRMEN1KMT2ASPRHPGD | |
| SCHEMBL8537710 | 0.87 | MEN1 (0.48) | TSHRMEN1KMT2ASPRHPGD | |
| SCHEMBL253658 | 0.86 | CES2 (0.43) | TSHRMEN1KMT2ACES2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8241606-B2 | Synthesis of a radiofluorinated peptide using photolabile protecting groups | GE HEALTHCARE AS (NO) | 2012-08-14 | — | — | US | disclosed |
| US-20100022746-A1 | SYNTHESIS OF A RADIOFLUORINATED PEPTIDE USING PHOTOLABILE PROTECTING GROUPS | GE HEALTHCARE AS (NO) | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022746-A1 | SYNTHESIS OF A RADIOFLUORINATED PEPTIDE USING PHOTOLABILE PROTECTING GROUPS | QRFPR, DNPEP, VIP | TSHR 264/4885MEN1 192/4885KMT2A 2596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.